BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 33428801)

  • 1. Real-world effectiveness and tolerability of carbamazepine and oxcarbazepine in 354 patients with trigeminal neuralgia.
    Di Stefano G; De Stefano G; Leone C; Di Lionardo A; Di Pietro G; Sgro E; Mollica C; Cruccu G; Truini A
    Eur J Pain; 2021 May; 25(5):1064-1071. PubMed ID: 33428801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain.
    Di Stefano G; La Cesa S; Truini A; Cruccu G
    J Headache Pain; 2014 Jun; 15(1):34. PubMed ID: 24912658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
    Grant SM; Faulds D
    Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    Pain; 2002 Feb; 95(3):259-266. PubMed ID: 11839425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta-analysis.
    Wang QP; Bai M
    CNS Drugs; 2011 Oct; 25(10):847-57. PubMed ID: 21936587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia.
    Gomez-Arguelles JM; Dorado R; Sepulveda JM; Herrera A; Arrojo FG; Aragón E; Huete CR; Terrón C; Anciones B
    J Clin Neurosci; 2008 May; 15(5):516-9. PubMed ID: 18378142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):472-6. PubMed ID: 2738589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).
    Besi E; Boniface DR; Cregg R; Zakrzewska JM
    J Headache Pain; 2015; 16():563. PubMed ID: 26335440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia.
    Di Stefano G; Truini A; Cruccu G
    Drugs; 2018 Sep; 78(14):1433-1442. PubMed ID: 30178160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options.
    Di Stefano G; Maarbjerg S; Truini A
    J Headache Pain; 2019 Feb; 20(1):20. PubMed ID: 30782116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs used in the management of trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):439-50. PubMed ID: 1408017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-antiepileptic drugs for trigeminal neuralgia.
    Zhang J; Yang M; Zhou M; He L; Chen N; Zakrzewska JM
    Cochrane Database Syst Rev; 2013 Dec; (12):CD004029. PubMed ID: 24297506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on pharmacotherapy for trigeminal neuralgia.
    Pergolizzi JV; LeQuang JA; El-Tallawy SN; Wagner M; Ahmed RS; Varrassi G
    Expert Rev Neurother; 2024 Jun; ():1-14. PubMed ID: 38870050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up.
    Xiromerisiou G; Lampropoulos IC; Dermitzakis EV; Vikelis M; Marogianni C; Mysiris D; Argyriou AA
    Toxins (Basel); 2023 Aug; 15(9):. PubMed ID: 37755965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and evidence for the use of oxcarbazepine in neuropathic pain.
    Carrazana E; Mikoshiba I
    J Pain Symptom Manage; 2003 May; 25(5 Suppl):S31-5. PubMed ID: 12694990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine in neuropathic pain.
    Nasreddine W; Beydoun A
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1615-25. PubMed ID: 17922625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of trigeminal neuralgia.
    Zakrzewska JM
    Br Dent J; 1990 May; 168(10):399-401. PubMed ID: 2189471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine for neuropathic pain.
    Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity.
    Zakrzewska JM; Ivanyi L
    J Allergy Clin Immunol; 1988 Jul; 82(1):110-5. PubMed ID: 3392362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of trigeminal neuralgia.
    Sindrup SH; Jensen TS
    Clin J Pain; 2002; 18(1):22-7. PubMed ID: 11803299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.